Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Northern Africa has been developing at a steady pace in recent years, driven by a combination of customer preferences, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Customers in Northern Africa have been increasingly seeking out alternative forms of medicine, including traditional herbal remedies and natural supplements. This has led to a growing demand for Other Pharmaceuticals, which are often marketed as natural or plant-based remedies. In addition, there has been a rising awareness of the importance of preventive healthcare, which has further fueled the demand for these products.
Trends in the market: One of the key trends in the Other Pharmaceuticals market in Northern Africa is the growing popularity of traditional herbal remedies. Many consumers in the region believe that these remedies are safer and more effective than synthetic drugs, and as a result, they are willing to pay a premium for them. In addition, there has been a growing interest in natural supplements, which are seen as a way to support overall health and wellbeing.
Local special circumstances: Northern Africa is home to a rich tradition of herbal medicine, and many consumers in the region have a deep-seated belief in the healing power of plants. As a result, there is a strong cultural and historical affinity for natural remedies, which has helped to drive the growth of the Other Pharmaceuticals market. In addition, there are a number of local plants that are believed to have medicinal properties, and these have become popular ingredients in many of the products on the market.
Underlying macroeconomic factors: The Other Pharmaceuticals market in Northern Africa is also being driven by a number of underlying macroeconomic factors. One of the key drivers is the region's rapidly growing population, which has led to an increase in demand for healthcare products and services. In addition, there has been a rise in disposable incomes in many countries in the region, which has enabled consumers to spend more on healthcare and wellness products. Finally, there has been a growing trend towards self-care and self-medication, which has further fueled the demand for Other Pharmaceuticals.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
